Kezar Life Sciences to Participate in Two Upcoming Investor Conferences

Author's Avatar
Nov 09, 2022

Kezar+Life+Sciences%2C+Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced members of the executive team will participate in two upcoming investor conferences in November.